A detailed history of Acadian Asset Management LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 177,689 shares of ADPT stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
177,689
Holding current value
$1.14 Million
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.37 - $5.12 $598,811 - $909,767
177,689 New
177,689 $908,000
Q1 2024

May 10, 2024

BUY
$2.88 - $4.8 $466,954 - $778,257
162,137 New
162,137 $519,000
Q2 2020

Aug 12, 2020

SELL
$24.95 - $48.38 $78,467 - $152,155
-3,145 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$16.96 - $34.16 $5,172 - $10,418
-305 Reduced 8.84%
3,145 $87,000
Q4 2019

Feb 06, 2020

BUY
$24.56 - $32.8 $84,732 - $113,159
3,450 New
3,450 $103,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $913M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.